Biofil Chemicals Mandates Physical Shareholder Data Update For SEBI Compliance

Shareholders holding physical shares must update details to ensure electronic payments and services. This follows SEBI's Master Circular, referenced February 06, 2026, which mandates PAN, KYC, and bank details.

Company Filing Details

Biofil Chemicals & Pharmaceuticals Ltd. is directing all holders of physical shares to update their essential details. The update requires submission of PAN, KYC, bank account information, nomination, and contact particulars to the company's Registrar and Transfer Agent (RTA), M/s Ankit Consultancy Pvt. Ltd.

This initiative aligns with SEBI's directives to streamline shareholder data management. For non-compliant shareholders, dividends and other corporate benefits are paid only electronically, a rule effective since April 01, 2024.

Shareholders who fail to provide updated details will face restricted service requests and continue to receive dividends electronically. This underscores the urgency for compliance.

Why the Update is Important

This move by Biofil Chemicals ensures compliance with SEBI's push for digitized and accurate shareholder records. It aims to improve communication efficiency and facilitate direct credit of financial benefits, reducing potential delays and administrative hurdles.

For shareholders, it means ensuring their holdings are compliant to avoid any service disruptions and to receive dividends seamlessly.

Regulatory Context

The Securities and Exchange Board of India (SEBI) has been progressively tightening norms for physical shareholdings. A key directive from April 1, 2019, disallowed the transfer of physical securities, pushing investors towards dematerialization.

SEBI has also provided special windows, such as the one from February 5, 2026, to February 4, 2027, for converting older physical shares into demat form, indicating a broader regulatory focus on modernizing shareholding practices.

Key Actions for Shareholders

• Shareholders with physical scrip must promptly submit updated PAN, KYC, and bank details to the RTA.
• Non-compliant folios will continue to face restricted service requests.
• Dividends will only be paid electronically to compliant shareholders.
• The RTA, Ankit Consultancy Pvt. Ltd., will process these updates.

Shareholder Risks

The main risk for shareholders is missing the compliance window. This could lead to difficulties in receiving dividends and processing service requests for their physical holdings.

Sector Compliance

Major pharmaceutical peers like Sun Pharma, Divi's Laboratories, and Torrent Pharmaceuticals are also subject to similar SEBI regulations regarding shareholder data and dematerialization, necessitating comparable compliance efforts across the sector.

What to Monitor Next

• Shareholder response to the mandatory data update request.
• The processing efficiency of Biofil Chemicals and its RTA in updating records.
• Any further SEBI directives on physical share compliance.